| 1. |
J3-50108 |
DEBIO 1143 has a potential to increase effectiveness of electrochemotherapy and radiotherapy in HPV positive and HPV negative Head and Neck Cancers |
10/1/2023
-
9/30/2026 |
PhD Katarina Žnidar
|
2,191 |
| 2. |
J4-50150 |
Erythrocyte membrane-based nanocarriers for gene silencing cancer therapy |
10/1/2023
-
9/30/2026 |
PhD Nina Kostevšek
|
3,902 |
| 3. |
L3-50111 |
Gene immuno-therapy of solid tumors based on mRNA encoding interleukin-12: So-rIL |
10/1/2023
-
9/30/2026 |
PhD Maja Čemažar
|
2,831 |
| 4. |
J3-50110 |
Intratumoral mRNA electrotransfer: establishment and preclinical proof of concept |
10/1/2023
-
9/30/2026 |
PhD Katja Uršič Valentinuzzi
|
3,082 |
| 5. |
V3-2320 |
Pilot implementation REsearch for revision of screening policy in the NatiOnal cerVicAl cancer screening programme ZORA (PRENOVA ZORA) |
10/1/2023
-
9/30/2026 |
PhD Urška Ivanuš
|
2,980 |
| 6. |
J2-50068 |
Safety and efficacy of high frequency electrochemotherapy - clinical device development |
10/1/2023
-
9/30/2026 |
PhD Matej Reberšek
|
3,467 |
| 7. |
J7-50128 |
Trace metals disorder as biomarker in biliary tract cancers |
10/1/2023
-
9/30/2026 |
PhD Janez Ščančar
|
3,646 |
| 8. |
V3-2326 |
Establishing an epidemiological basis for the introduction of new national cancer screening programmes in Slovenia |
10/1/2023
-
9/30/2025 |
PhD Tina Žagar
|
987 |
| 9. |
V3-2321 |
Framework development for evidence-based, sustainable implementation of organised population-based lung cancer screening in Slovenia (LUKA) |
10/1/2023
-
9/30/2025 |
PhD Martina Vrankar
|
2,217 |
| 10. |
V3-2322 |
Framework development for evidence-based, sustainable implementation of organised population-based screening for prostate cancer in Slovenia (PETER) |
10/1/2023
-
9/30/2025 |
PhD Irena Oblak
|
3,110 |
| 11. |
Z3-50112 |
Irradiation and trained immunity: The role of NK cells |
10/1/2023
-
9/30/2025 |
PhD Tim Božič
|
52 |
| 12. |
L7-4491 |
Development of integrated multi-channel artificial nose for detection of cancer |
10/1/2022
-
9/30/2025 |
PhD Igor Muševič
|
5,466 |
| 13. |
J1-4417 |
Development of novel small molecule Toll-like receptors 7 and 8 modulators for cancer immunotherapy |
10/1/2022
-
9/30/2025 |
PhD Matej Sova
|
3,916 |
| 14. |
J7-4635 |
MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy |
10/1/2022
-
9/30/2025 |
PhD Lucija Peterlin Mašič
|
6,047 |
| 15. |
V3-2239 |
Needs assessment, identification of criteria and development of a model for the organization of palliative cancer care at the national level |
10/1/2022
-
9/30/2025 |
PhD Vesna Zadnik
|
1,421 |
| 16. |
J7-4540 |
Socio-economic consequences of cancer from the perspective of the individual and society including the impact of COVID-19 pandemic |
10/1/2022
-
9/30/2025 |
PhD Ivica Ratoša
|
4,709 |
| 17. |
J3-4504 |
Uncovering the glioblastoma microenvironment to enhance the therapy |
10/1/2022
-
9/30/2025 |
PhD Metka Novak
|
1,771 |
| 18. |
BI-AT/23-24-027 |
Evaluation of a novel mouse HPV positive oral squamous cell carcinoma model |
1/1/2023
-
12/31/2024 |
PhD Simona Kranjc Brezar
|
315 |
| 19. |
BI-AT/23-24-004 |
The role of necroptosis in acute myeloid leukemia |
1/1/2023
-
12/31/2024 |
PhD Maja Čemažar
|
1,425 |
| 20. |
N1-0197 |
Improving breast cancer screening through dynamic big data analytics of Quantitative Imaging Biomarkers (QIB) |
1/1/2021
-
12/31/2024 |
PhD Robert Jeraj
|
2,732 |
| 21. |
V3-2236 |
Assessment of the potential impact of incineration and co-incineration of waste on human health effects: a model study on the case of the Salonit Anhovo cement plant |
10/1/2022
-
9/30/2024 |
PhD Andreja Kukec
|
8,738 |
| 22. |
V3-2241 |
Pilot Research on Individualized Comprehensive Rehabilitation of patients with colorectal cancer 2022-2024 |
10/1/2022
-
9/30/2024 |
PhD Nada Rotovnik Kozjek
|
4,261 |
| 23. |
J3-3062 |
Autologous immunohybridomas and advanced treatment of stage II and III triple-negative breast cancer |
10/1/2021
-
9/30/2024 |
PhD Matjaž Jeras
|
2,521 |
| 24. |
J3-3084 |
Inducible Programming of CAR T Cell Intrinsic Properties for Cancer Immunotherapy |
10/1/2021
-
9/30/2024 |
PhD Anže Smole
|
2,497 |
| 25. |
J2-3059 |
Online adaptive re-planning in proton and radiotherapy |
10/1/2021
-
9/30/2024 |
PhD Žiga Špiclin
|
2,107 |
| 26. |
J3-3083 |
Vascularization and vascular effects as predictive factors for local ablative techniques |
10/1/2021
-
9/30/2024 |
PhD Gregor Serša
|
6,765 |
| 27. |
J3-2537 |
New method for estimating life-years gained in population-based cancer screening programmes (S-LYG) |
9/1/2020
-
8/31/2024 |
PhD Vesna Zadnik
|
3,061 |
| 28. |
BI-US/22-24-026 |
Biomarkers to aid the efficacy of electrochemotherapy in combination with immunogenic therapy for cancer treatment |
7/1/2022
-
6/30/2024 |
PhD Gregor Serša
|
1,511 |
| 29. |
BI-US/22-24-070 |
Demonstration of the possibility of linking results between three-dimensional biometric vessel models and tumor vessels in vivo |
7/1/2022
-
6/30/2024 |
PhD Boštjan Markelc
|
224 |
| 30. |
L3-2622 |
Biological markers of risk for development, progression and treatment response in asbestos related diseases |
9/1/2020
-
8/31/2023 |
PhD Vita Dolžan
|
3,233 |
| 31. |
J3-2530 |
EFFECT OF ENDOCRINE DISRUPTORS (BISPHENOLS, PARABENS, TRICLOSAN) AND POTENTIALLY TOXIC AND ESSENTIAL CHEMICAL ELEMENTS ON THE BIRTH, INFERTILITY AND OVARIAN CANCER IN SLOVENIA |
9/1/2020
-
8/31/2023 |
PhD Irma Virant Klun
|
7,187 |
| 32. |
Z3-2651 |
Electrochemotherapy as in situ vaccination therapy |
9/1/2020
-
8/31/2023 |
PhD Katja Uršič Valentinuzzi
|
93 |
| 33. |
J3-2528 |
Immuno gene electrotransfer of IL-12 and IL-2 in immunologically cold/hot tumors |
9/1/2020
-
8/31/2023 |
PhD Maja Čemažar
|
3,171 |
| 34. |
J3-2524 |
Minimally invasive diagnostic approaches in brain tumours using circulating cell-free nucleic acids |
9/1/2020
-
8/31/2023 |
PhD Jože Pižem
|
1,805 |
| 35. |
J4-2546 |
Monitoring of the clinical and immune response to improve the outcome of combined electrochemotherapy and IL-12 gene therapy in dogs with spontaneous peripheral tumours |
9/1/2020
-
8/31/2023 |
PhD Nataša Tozon
|
3,553 |
| 36. |
J3-2527 |
New approaches for prediction of cardiotoxicity in breast cancer radiotherapy |
9/1/2020
-
8/31/2023 |
PhD Tanja Marinko
|
2,317 |
| 37. |
J3-2529 |
Role of endothelium in tumor response to radiotherapy |
9/1/2020
-
8/31/2023 |
PhD Boštjan Markelc
|
3,335 |
| 38. |
J7-2594 |
The amniotic membrane as a novel multimodal therapy for bacterial cystitis and bladder cancer: unravelling its antimicrobial, immunomodulatory and anticancer activity |
9/1/2020
-
8/31/2023 |
PhD Mateja Erdani Kreft
|
5,127 |
| 39. |
V3-1906 |
Pilot study on individualized integrated rehabilitation of breast cancer patients 2019-2022 |
11/1/2019
-
4/30/2023 |
PhD Nikola Bešić
|
3,905 |
| 40. |
V3-1911 |
Slovenian genome project |
11/1/2019
-
10/31/2022 |
PhD Borut Peterlin
|
8,653 |
| 41. |
V3-2032 |
The impact of COVID-19 on the cancer management in Slovenia |
10/1/2020
-
9/30/2022 |
PhD Tina Žagar
|
2,046 |
| 42. |
Z3-1873 |
A novel vascular targeted approach based on gene therapy silencing two independent
signaling pathways in combination with radiotherapy |
7/1/2019
-
7/31/2022 |
PhD Monika Savarin
|
62 |
| 43. |
J2-1732 |
Computer-assisted medical image analysis for proton and radiotherapy treatment planning |
7/1/2019
-
6/30/2022 |
PhD Tomaž Vrtovec
|
1,807 |
| 44. |
J3-1753 |
Molecular predictors of radiation treatment response in breast cancer |
7/1/2019
-
6/30/2022 |
PhD Katja Goričar
|
1,627 |
| 45. |
J3-1760 |
The role of imaging and laboratory markers in the evaluation of nature and growth of thyroid nodules |
7/1/2019
-
6/30/2022 |
PhD Katja Zaletel
|
1,713 |
| 46. |
J5-9336 |
Opportunities and dangers of online health communities for healthcare |
7/1/2018
-
6/30/2022 |
PhD Gregor Petrič
|
1,870 |
| 47. |
V3-1907 |
Development of indicators and methodology for monitoring the late effects of cancer treatment in childhood at national level |
11/1/2019
-
10/31/2021 |
PhD Vesna Zadnik
|
2,200 |
| 48. |
Z3-1871 |
Combination of electrochemotherapy with poly (adenosin diphosphate-ribose) polymerase inhibitor in treatment of breast cancer |
7/1/2019
-
6/30/2021 |
PhD Maša Omerzel
|
198 |
| 49. |
J3-9269 |
Clinico-pharmacological approach to optimize the therapeutic bleomycin concentration in
patients undergoing electrochemotherapy |
7/1/2018
-
6/30/2021 |
PhD Gregor Serša
|
3,493 |
| 50. |
J2-9225 |
Non-invasive technique for Cell Membrane Permeabilization using pulsed electromagnetic fields |
7/1/2018
-
6/30/2021 |
PhD Damijan Miklavčič
|
2,899 |
| 51. |
V3-1718 |
Health risk assessment for exposures of children to low-frequency electric and magnetic (EM) fields in Slovenia |
4/1/2018
-
3/31/2021 |
PhD Tadej Kotnik
|
2,514 |
| 52. |
N3-0059 |
Plasma-assisted wound treatment and topical introduction of molecules |
1/1/2017
-
12/31/2020 |
PhD Uroš Cvelbar
|
3,036 |
| 53. |
J4-8227 |
Cathepsin X inhibitors impair the resistence of tumor cells to antiprotease therapy
|
5/1/2017
-
4/30/2020 |
PhD Janko Kos
|
4,549 |
| 54. |
J1-8140 |
Endocrine disrupting and genotoxic potential of protein kinase inhibitors: relevance for
environmental hazard in zdravje ljudi |
5/1/2017
-
4/30/2020 |
PhD Metka Filipič
|
3,735 |
| 55. |
J3-8210 |
Potential of low, sub-therapeutic doses of statins and sartans in primary and secondary cardiovascular disease prevention |
5/1/2017
-
4/30/2020 |
PhD Mirza Šabovič
|
2,430 |
| 56. |
L3-8203 |
Serum, genetic and epigenetic markers of risk for developing, progress and treatment response in asbestos related diseases |
5/1/2017
-
4/30/2020 |
PhD Vita Dolžan
|
2,983 |
| 57. |
J3-8202 |
Time-lapse intra-vital imaging of immune response after electrochemotherapy induced in situ vaccination and Interleukin-12 gene therapy boost |
5/1/2017
-
4/30/2020 |
PhD Maja Čemažar
|
3,536 |
| 58. |
V3-1720 |
Analysis and estimation of requirements of human resources for cancer treatment in Slovenia |
4/1/2018
-
3/31/2020 |
PhD Branko Zakotnik
|
4,499 |
| 59. |
V3-1713 |
Comprehensive analysis of management of urological cancer patients with an assessment of possible delays in referrals, realization of diagnostics procedures and first treatment |
4/1/2018
-
3/31/2020 |
PhD Vesna Zadnik
|
3,961 |
| 60. |
Z3-8204 |
Involvement of cytosolic DNA sensors in irradiation induced bystander and abscopal effect |
4/1/2018
-
3/31/2020 |
PhD Tanja Jesenko
|
168 |
| 61. |
V3-1638 |
Development and implementation of personalised breast cancer risk evaluation tool for Slovenian population |
10/1/2016
-
9/30/2019 |
PhD Vesna Zadnik
|
3,088 |
| 62. |
L2-7550 |
Elecrospun nanofibrous materials for solid state drug delivery system |
3/1/2016
-
2/28/2019 |
PhD Igor Emri
|
4,423 |
| 63. |
J3-7460 |
Irradiation dose modifying factor of squamous cell carcinoma of the oropharynx infected by human papillomavirus: an in vitro and in vivo study in laboratory mouse tumor model |
1/1/2016
-
12/31/2018 |
PhD Primož Strojan
|
4,254 |
| 64. |
J3-7272 |
Methods of estimation of key indicators in population cancer survival |
1/1/2016
-
12/31/2018 |
PhD Maja Pohar Perme
|
3,020 |
| 65. |
J3-7372 |
Molecular biomarkers and biomarker-driven therapy in lung cancer |
1/1/2016
-
12/31/2018 |
PhD Tanja Čufer
|
4,669 |
| 66. |
J3-7494 |
Tunneling nanotubes for innovative urinary bladder cancer treatments |
1/1/2016
-
12/31/2018 |
PhD Mateja Erdani Kreft
|
7,076 |
| 67. |
J1-6730 |
Development of new hepatic cell lines for genotoxicity and carcinogenicity studies: new hope for human health and laboratory animal welfare protection |
11/1/2014
-
10/31/2017 |
PhD Metka Filipič
|
4,041 |
| 68. |
J1-6744 |
Development of Molecularly Imprinted Polymers and their application in environmental and bio-analysis |
7/1/2014
-
6/30/2017 |
PhD Tina Kosjek
|
4,807 |
| 69. |
J3-6793 |
New approaches of tumor radiosenzibilization with gene therapy |
7/1/2014
-
6/30/2017 |
PhD Gregor Serša
|
5,089 |
| 70. |
J3-6795 |
The textural analysis of spatiotemporal changes for breast lesions diagnosis on ultrafast breast MRIs |
7/1/2014
-
6/30/2017 |
PhD Janez Žgajnar
|
1,517 |
| 71. |
J3-6796 |
Translational oncology: development and validtion of immunogene therapy with Interleukin-12 combined with surgery for canine cancers of the oral cavity and skin
|
7/1/2014
-
6/30/2017 |
PhD Maja Čemažar
|
4,735 |
| 72. |
J2-5474 |
Development of in-vivo dosimetry for applications in radiotherapy |
8/1/2013
-
7/31/2016 |
PhD Gregor Kramberger
|
3,303 |
| 73. |
J3-5505 |
Electrochemotherapy in treatment of deep seated tumors |
8/1/2013
-
7/31/2016 |
PhD Gregor Serša
|
4,266 |
| 74. |
J4-5529 |
Nitroxoline and its derivatives as new antitumour drugs |
8/1/2013
-
7/31/2016 |
PhD Janko Kos
|
5,945 |
| 75. |
L3-5512 |
Pilot project on acceptability and quality of HPV self sampling in non-responders to National Cervical Cancer Screening Programme NP ZORA |
8/1/2013
-
7/31/2016 |
PhD Maja Primic-Žakelj
|
4,592 |
| 76. |
J3-4211 |
Antiangiogenic gene therapy of cancer using electroporation and magnetic nanoparticles as targeted delivery systems |
7/1/2011
-
6/30/2014 |
PhD Gregor Serša
|
6,452 |
| 77. |
J1-4044 |
Apoptotic effects of alkylpyridinium compounds on lung adenocarcinoma cells |
7/1/2011
-
6/30/2014 |
PhD Tom Turk
|
6,256 |
| 78. |
L2-4105 |
Development and validation of a software for numerical modeling of in vivo electroporation - in silico electroporation |
7/1/2011
-
6/30/2014 |
PhD Damijan Miklavčič
|
4,815 |
| 79. |
J3-4259 |
Preparation and validation of therapeutic plasmids without selection gene for antibiotic resistance for cancer gene therapy using inducible and tissue-specific promoters |
7/1/2011
-
6/30/2014 |
PhD Maja Čemažar
|
5,841 |
| 80. |
J3-4118 |
Somatic mutations in genes responsible for melanoma development and clinical disease prognosis |
7/1/2011
-
6/30/2014 |
PhD Marko Hočevar
|
2,195 |
| 81. |
J1-4131 |
Synthesis, characterisation and use of novel ruthenium compounds in electrochemotherapy of tumors |
7/1/2011
-
6/30/2014 |
PhD Iztok Turel
|
5,932 |
| 82. |
J3-4195 |
USTVARJANJE LINIJE MULTIPOTENTNIH / PLURIPOTENTNIH MATIČNIH CELIC IZ ODRASLEGA HUMANEGA TKIVA JAJČNIKA IN MOD: PERSPEKTIVA ZA REPRODUKTIVNO IN REGENERATIVNO MEDICINO. (Slovene) |
7/1/2011
-
6/30/2014 |
PhD Irma Virant Klun
|
3,445 |
| 83. |
J2-3639 |
New lipid model systems for determination of electroporation basic mechanisms |
5/1/2010
-
4/30/2013 |
PhD Damijan Miklavčič
|
5,131 |
| 84. |
V3-1049 |
Študija celostnega sklapljanja zdravstvenih in okoljskih podatkov v Zasavju kot model študije za podporo pri oblikovanju in izvajanju medsektorskih politik s področja okolja in zdravja (Slovene) |
10/1/2010
-
9/30/2012 |
PhD Jerneja Farkaš-Lainščak
|
4,313 |
| 85. |
J3-2359 |
Genetska in terapevtska raznolikost bolnikov pri načrtovanju individualizirane terapije pljučnega raka (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Mitja Košnik
|
4,288 |
| 86. |
J3-2277 |
Kombinacija elektrogenske imunske terapije z interlevkinom-12 in obsevanjem za zdravljenje eksperimentalnih tumorjev (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Maja Čemažar
|
2,816 |
| 87. |
L3-2371 |
Ocena preživetja bolnic z napredovalim karcinomom jajčnikov glede na primarno oziroma laparoskopsko ocenjeno optimalno citoredukcijo (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Borut Kobal
|
2,045 |
| 88. |
J3-2069 |
Uporaba magnetne nanotehnologije za transfekcijo normalnih in tumorskih celic (Slovene) |
5/1/2009
-
4/30/2012 |
PhD Gregor Serša
|
2,786 |
| 89. |
V3-1048 |
Izdelava strokovnih podlag za zbiranje in spremljanje izbranih kazalnikov učinkovitosti Državnega programa obvladovanja raka (Slovene) |
10/1/2010
-
3/31/2012 |
PhD Maja Primic-Žakelj
|
5,276 |
| 90. |
J3-0485 |
Antiangiogenic siRNA for the treatment of advanced malignant melanoma |
2/1/2008
-
1/30/2011 |
PhD Maja Čemažar
|
2,583 |
| 91. |
L3-0113 |
Development and validation of clinical tools developed on International Classification of Functioning, Health and Disability (ICF) |
2/1/2008
-
1/30/2011 |
PhD Helena Burger
|
3,117 |
| 92. |
J3-0465 |
Editing of immunosurviellance with the whole cell tumor vaccines and CpG ODN |
2/1/2008
-
1/30/2011 |
PhD Srdjan Novaković
|
1,688 |
| 93. |
J3-0570 |
Genetic and radioisotopic methods in diagnostics and therapy of thyroid carcinoma |
2/1/2008
-
1/30/2011 |
PhD Nikola Bešić
|
1,935 |
| 94. |
L3-0431 |
Genetics of breast cancer and hormone replacement therapy |
2/1/2008
-
1/30/2011 |
PhD Ksenija Geršak
|
3,739 |
| 95. |
J3-0480 |
Genetics of hereditary melanoma |
2/1/2008
-
1/30/2011 |
PhD Marko Hočevar
|
1,534 |
| 96. |
L3-0494 |
Method for multimodal comparative analysis of 3D volumes, based on CT/MR images |
2/1/2008
-
1/30/2011 |
PhD Robert Hudej
|
291 |
| 97. |
L3-0449 |
New approaches in the treatment of lung cancer II. |
2/1/2008
-
1/30/2011 |
PhD Matjaž Zwitter
|
1,956 |
| 98. |
J1-0200 |
Synthesis of novel ruthenium compounds and their potential use in electrochemotherapy of tumors |
2/1/2008
-
1/30/2011 |
PhD Iztok Turel
|
4,373 |
| 99. |
J3-0124 |
The role of recombinant human erythropoietin on gene expression and signal transduction in breast cancer |
2/1/2008
-
1/30/2011 |
PhD Nataša Debeljak
|
3,805 |
| 100. |
J3-0020 |
Three-dimensional analysis of the face among Slovenian children in the period of growth and development |
2/1/2008
-
1/30/2011 |
PhD Maja Ovsenik
|
1,177 |
| 101. |
L3-9346 |
Analysis of late effects after treatment of cancer in children and young adults |
7/1/2007
-
6/30/2010 |
PhD Berta Jereb
|
2,626 |
| 102. |
J3-9580 |
Development of cell biosensor systems for determination of effects of ionizing radiation and chemical carcinogens |
1/1/2007
-
12/31/2009 |
PhD Gregor Serša
|
2,466 |
| 103. |
J3-9161 |
Fertility after testicular cancer treatment |
1/1/2007
-
12/31/2009 |
PhD Branko Zorn
|
3,653 |
| 104. |
L2-9212 |
Verification of radioactive sources positioning during brachytherapy |
1/1/2007
-
12/31/2009 |
PhD Gregor Kramberger
|
2,265 |
| 105. |
M1-0153 |
Biološka dozimetrija na osnovi magnetno resonančnih metod (Slovene) |
6/1/2006
-
11/30/2008 |
PhD Marjeta Šentjurc
|
6,892 |
| 106. |
V3-0371 |
Znanstveno raziskovalni zavodi na področju biomedicinskih znanosti - izsledki biomedicinskih raziskav in učinkovita oblika organiziranosti (Slovene) |
10/1/2006
-
9/30/2008 |
PhD Bojan Zalar
|
5,120 |
| 107. |
J3-7488 |
Hereditary breast and ovarian cancer in Slovenia |
9/1/2005
-
8/31/2008 |
PhD Janez Žgajnar
|
3,567 |
| 108. |
J3-7044 |
Treatment of malignant tumours with electrogene therapy |
9/1/2005
-
8/31/2008 |
PhD Maja Čemažar
|
3,349 |
| 109. |
J3-6083 |
Dedni melanom pri Slovencih (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Marko Hočevar
|
2,159 |
| 110. |
J3-6092 |
Genetske in radioizotopne metode v diagnostiki in terapiji raka ščitnice (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Nikola Bešić
|
2,055 |
| 111. |
J3-6389 |
Kirurgija raka prebavil (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Stanislav Repše
|
2,946 |
| 112. |
J3-6044 |
Nove poti zdravljenja pljučnega raka (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Matjaž Zwitter
|
2,763 |
| 113. |
L3-6068 |
Primerjava potekov bolezni bolnic z mikrometastazo v prvi bezgavki, ki so prestale disekcijo pazduhe, s poteki onih, ki so bile zgolj opazovane (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Jurij Lindtner
|
2,040 |
| 114. |
J3-6363 |
Priprava tumorskih vakcin: hibridomi in gensko spremenjene vakcine (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Srdjan Novaković
|
2,462 |
| 115. |
J3-6063 |
Rak materničnega vratu pri ženskah z rednimi ginekološkimi pregledi - zagotavljanje in nadziranje kakovosti presejanja (Slovene) |
7/1/2004
-
6/30/2007 |
PhD Marjetka Uršič Vrščaj
|
1,596 |
| 116. |
L3-6039 |
Kasne posledice zdravljenja raka pri otrocih in mladih odraslih (Slovene) |
2/1/2004
-
1/30/2007 |
PhD Berta Jereb
|
2,968 |
| 117. |
L3-6059 |
Prospektivna randomizirana klinična raziskava faze ll: 5-FU/LV in Irinotekan v primerjavi s kombinacijo Kapecitabin in Irinotekan v prvem zdravljenju metastatske bolezni pri bolnikih s karcinomom debelega črevesa in danke (Slovene) |
2/1/2004
-
1/30/2007 |
PhD Janja Ocvirk
|
1,839 |
| 118. |
J3-6260 |
Vpliv infuzij nizkih odmerkov citostatikov na tumorske celice in pretok krvi v tumorjih (Slovene) |
2/1/2004
-
1/30/2007 |
PhD Marija Auersperg
|
4,348 |
| 119. |
Z3-6144 |
Raziskava možnosti uporabe parafina za filtrski kompenzator v megavoltni radioterapiji (Slovene) |
2/1/2004
-
1/30/2006 |
PhD Primož Strojan
|
855 |
| 120. |
L3-5074 |
EARLY DETECTION OF LUNG CANCER AND RISK FACTORS FOR DEVELOPMENT AND PROGRESS OF DISEASE |
1/1/2003
-
12/31/2005 |
PhD Marjeta Terčelj Zorman
|
2,407 |
| 121. |
L3-5234 |
Genotoxic and late effect of treatment on somatic cells of patients with testicular tumor |
1/1/2003
-
12/31/2005 |
PhD Cvetka Bilban-Jakopin
|
836 |
| 122. |
J3-5296 |
Model of artificial neural networks (ANN) - help for clinicians in selecting adjuvant treatment in breast cancer patients |
1/1/2003
-
12/31/2005 |
PhD Branko Zakotnik
|
1,055 |
| 123. |
L3-5012 |
MOLEKULAR GENETIC PREDISPOSITION FOR DEVELOPMENT OF SOME CANCERS |
1/1/2003
-
12/31/2005 |
PhD Metka Ravnik-Glavač
|
4,636 |
| 124. |
J3-5299 |
Vpliv novih metod patologije in klinike na rezultate zdravljenja bolnikov s tumorji EWing/PNET (Slovene) |
1/1/2003
-
12/31/2005 |
PhD Živa Pohar Marinšek
|
1,842 |
| 125. |
J3-5325 |
Kasne posledice na ledvicah po zdravljenju raka pri otrocih (Slovene) |
1/1/2003
-
6/30/2005 |
PhD Radoslav Kveder
|
2,952 |
| 126. |
J3-4203 |
Adjuvantno zdravljenje bolnikov z malignim melanomom stadij llB,C z interferonom alfa-2A (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Zvonimir Rudolf
|
4,394 |
| 127. |
J3-4308 |
Napovedni pomen katepsinov in stefinov pri napredovalnem karcinomu glave in vratu zdravljenem s konkomitantno radiokemoterapijo (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Alojz Šmid
|
2,055 |
| 128. |
J3-4291 |
Napovedni pomen proteinov uPA sistema za odgovor na sistemsko zdravljenje in za lokalno ponovitev bolezni pri bolnicah z rakom dojk (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Tanja Čufer
|
4,470 |
| 129. |
J3-4207 |
Ocena učinkovitosti presejanja za raka materničnega vratu v Sloveniji; študija primerov s kontrolami (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Maja Primic-Žakelj
|
3,168 |
| 130. |
J3-4178 |
Pomen okultnih metastaz v pazdušnih bezgavkah pri zgodnjem karcinomu dojke (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Matej Bračko
|
2,071 |
| 131. |
L3-4278 |
Po odstranitvi varovalne bezgavke: Obsevanje ali kirurgija (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Marko Snoj
|
1,827 |
| 132. |
J3-4176 |
Predklinične raziskave elektrogenske terapije v onkologiji (Slovene) |
7/1/2002
-
6/30/2005 |
PhD Maja Čemažar
|
4,831 |
| 133. |
J3-3501 |
Creation of tumor vaccines |
7/1/2001
-
6/30/2004 |
PhD Srdjan Novaković
|
3,488 |
| 134. |
J3-3104 |
Diagnostics and therapy of the nonpalpable breast cancer |
7/1/2001
-
6/30/2004 |
PhD Jurij Lindtner
|
1,543 |
| 135. |
J3-3495 |
Flow Cytometric Immunophenotyping in Diagnosis, Prognosis and Treatment of non-Hodgkin's Lymphomas |
7/1/2001
-
6/30/2004 |
PhD Veronika Kloboves-Prevodnik
|
1,300 |
| 136. |
J3-3460 |
Genetic and radioisotopic methods in diagnosis and therapy of thyroid carcinoma |
7/1/2001
-
6/30/2004 |
PhD Nikola Bešić
|
1,847 |
| 137. |
J3-3395 |
Genetic causes of female infertility 2
|
7/1/2001
-
6/30/2004 |
PhD Ksenija Geršak
|
4,563 |
| 138. |
J3-3010 |
Inoperable carcinoma of the head and neck: an attempt to improve treatment results and analysis of some biological characteristics |
7/1/2001
-
6/30/2004 |
PhD Primož Strojan
|
2,584 |
| 139. |
L3-3375 |
Introduction of threedimensional radiotherapy treatment planning in Slovenia |
7/1/2001
-
6/30/2004 |
PhD Hotimir Lešničar
|
5,911 |
| 140. |
J3-3076 |
Lipid peroxidation and functional damage in target tissues and organs in citizens of Idrija and mercury miners exposed to the elemental mercury |
7/1/2001
-
6/30/2004 |
PhD Joško Osredkar
|
6,140 |
| 141. |
J3-3021 |
Multimodality treatment for lung cancer |
7/1/2001
-
6/30/2004 |
PhD Matjaž Zwitter
|
1,796 |
| 142. |
J3-3489 |
New biomedical applications of electroporation |
7/1/2001
-
6/30/2004 |
PhD Gregor Serša
|
4,059 |
| 143. |
J3-3497 |
Phyllodes tumor of the breast. Histological, cytological, immunohistochemical and nuclear texture features in prediction of its biological behavior |
7/1/2001
-
6/30/2004 |
PhD Janez Lamovec
|
1,447 |
| 144. |
J3-3101 |
Quantitative image analysis of non-small cell lung cancer: estimation of biological potential and treatment planning based on DNA ploidy and nuclear texture features |
7/1/2001
-
6/30/2004 |
PhD Margareta Strojan Fležar
|
2,056 |
| 145. |
J3-3026 |
Role of cytomorphology, DNA measurements, Ki 67 and apoptosis for planning and predicting the effect of chemotherapy in thyroid cancer |
7/1/2001
-
6/30/2004 |
PhD Ana Pogačnik
|
3,436 |
| 146. |
J3-3464 |
Role of tyrosinase RT-PCR in staging of patients with malignant melanoma |
7/1/2001
-
6/30/2004 |
PhD Marko Hočevar
|
2,791 |
| 147. |
J3-3303 |
Surgery for gastrointestinal cancer |
7/1/2001
-
6/30/2004 |
PhD Stanislav Repše
|
2,667 |
| 148. |
J3-3506 |
The Role of High risk Human Papilloma Viruses in the Detection of Cervical Cancer
|
7/1/2001
-
6/30/2004 |
PhD Marjetka Uršič Vrščaj
|
1,932 |
| 149. |
J3-2450 |
Biološke značilnosti raka glave in vratu in uspeh zdravljenja (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Alojz Šmid
|
1,757 |
| 150. |
J3-2411 |
Histološki in imunohistokemični napovedi dejavniki pri karcinomu dojke v stadiju I (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Matej Bračko
|
2,371 |
| 151. |
J3-2165 |
Napovedni pomen proteinov uPA sistema in katepsinov za prezivetje in odgovor na sistemsko zdravljenje bolnic z rakom dojk (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Tanja Čufer
|
4,534 |
| 152. |
L3-2061 |
Psihosocialni vplivi raka dojke na druzinsko zivljenje (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Maja Primic-Žakelj
|
1,135 |
| 153. |
J3-2049 |
Uporaba elektroporacij v genski terapiji (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Maja Čemažar
|
4,102 |
| 154. |
L3-2161 |
Varovalna bezgavka (Slovene) |
1/1/2000
-
6/30/2002 |
PhD Marko Snoj
|
1,434 |
| 155. |
L3-1259 |
Modulacija imunskega odziva pri bolnikih z malignim melanomom rezistentnim na kemoterapijo (Slovene) |
1/1/1999
-
6/30/2001 |
PhD Borut Štabuc
|
2,813 |
| 156. |
J3-1220 |
Napovedna vrednost oksigeniranosti tumorjev pri izbranih bolnikih z malignomom glave in vratu (Slovene) |
1/1/1999
-
6/30/2001 |
PhD Hotimir Lešničar
|
2,537 |
| 157. |
L3-1192 |
PovejMi: telemedicinska pomoč bolnicam z rakom dojke (Slovene) |
1/1/1999
-
6/30/2001 |
PhD Ankica Babič
|
3,775 |
| 158. |
L3-1008 |
Razpoznavanje pljučnih okužb pri jatrogeno imunosuprimiranih bolnikih (Slovene) |
1/1/1999
-
6/30/2001 |
PhD Aleksandra Skralovnik-Štern
|
1,459 |
| 159. |
J3-0428 |
Genetski dejavniki pri ženski neplodnosti (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Ksenija Geršak
|
2,456 |
| 160. |
J3-0097 |
Okužbe z virusi papiloma pri intraepitelijskem raku materničnega vratu (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Marjetka Uršič Vrščaj
|
1,445 |
| 161. |
J3-0123 |
Protitelesa proti proteinu p53 in p53 v serumu bolnikov z malignimi tumorji (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Zvonimir Rudolf
|
3,628 |
| 162. |
J3-0143 |
Raziskave zdravljenja pljučnega raka: etična in klinična razpotja (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Matjaž Zwitter
|
737 |
| 163. |
J1-0640 |
Serumske vrednosti cisteinskih proteinaz katepsinov B, H in L in njihovih inhibitorjev stefinov in cistatinov kot pokazateljev diagnoze (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Janko Kos
|
2,278 |
| 164. |
J3-0146 |
Zdravljenje malignih solidnih tumorjev z interferonom alfa (Slovene) |
7/1/1998
-
6/30/2001 |
PhD Borut Štabuc
|
2,322 |
| 165. |
J3-8752 |
Napoved incidence raka v Sloveniji do leta 2000 in 2010 (Slovene) |
1/1/1997
-
6/30/2001 |
PhD Vera Pompe-Kirn
|
1,393 |
| 166. |
J3-7843 |
Elektrokemoterapija - nov pristop k zdravljenju raka (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Gregor Serša
|
4,125 |
| 167. |
J3-7919 |
Genetska analiza nekaterih tumor supresor genov (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Metka Ravnik-Glavač
|
1,363 |
| 168. |
J3-7841 |
Kirurgija raka prebavil - primerjava želodčnega in kolorektalnega raka (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Stanislav Repše
|
1,177 |
| 169. |
J3-7953 |
Konvencionalne in moderne kvantitativne metode pri oceni progresije sarkomov mehkih tkiv (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Rastko Golouh
|
2,431 |
| 170. |
J3-7952 |
Poskus izboljšanja zdravljenja malignih tumorjev, zmanjšanja posledic zdravljenja in proučevanje prognostičnih dejavnikov (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Marjan Budihna
|
2,104 |
| 171. |
J3-7842 |
Racionalna diagnostika in zdravljenje tumorjev ščitnice (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Nikola Bešić
|
2,968 |
| 172. |
J3-7878 |
Razvoj avtolognih tumorskih vakcin (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Srdjan Novaković
|
5,623 |
| 173. |
J1-7428 |
Regulation of gene expression by steroids in primitive eucaryots and the application of P450 gene technology in medicine |
1/1/1996
-
6/30/2001 |
PhD Katja Breskvar
|
1,543 |
| 174. |
J3-7956 |
Slikovna citomerija pri detekciji, prognozi in zdravljenju malignih tumorjev (Slovene) |
1/1/1996
-
6/30/2001 |
PhD Veronika Kloboves-Prevodnik
|
3,106 |
| 175. |
L3-0362 |
Causes of constant inicidence of invasive cervical cancer in Slovenia |
7/1/1998
-
6/30/2000 |
PhD Stelio Rakar
|
1,835 |
| 176. |
L1-0469 |
Optimization of MDP and TNF analogues having therapeutic potential |
7/1/1998
-
6/30/2000 |
PhD Anton Štalc
|
6,231 |
| 177. |
L3-9202 |
Adjuvant systemic therapy in operable breast cancer patients |
11/1/1998
-
12/31/1999 |
PhD Jurij Lindtner
|
163 |
| 178. |
J3-8924 |
Analysis of late sequelae of cancer treatment in childhood |
1/1/1997
-
12/31/1999 |
PhD Berta Jereb
|
465 |
| 179. |
J3-8679 |
Apoptosis and the immune system |
1/1/1997
-
12/31/1999 |
PhD Vladimir Kotnik
|
6,502 |
| 180. |
J3-8743 |
Biological characteristics of head and neck cancer and the results of treatment |
1/1/1997
-
12/31/1999 |
PhD Alojz Šmid
|
1,107 |
| 181. |
J3-8748 |
Boron Neutron Capture Therapy - Employment of drug delivery systems for increased antitumor effectiveness |
1/1/1997
-
12/31/1999 |
PhD Janez Škrk
|
4,894 |
| 182. |
J3-8744 |
Phospholipase a2 in tumor tissue |
1/1/1997
-
12/31/1999 |
PhD Marko Snoj
|
1,158 |
| 183. |
J3-8746 |
Prognostic value of uPA, PAI 1 and PAI 2 in solid tumors |
1/1/1997
-
12/31/1999 |
PhD Tanja Čufer
|
3,987 |
| 184. |
L3-8919 |
Proteaze in proteazni inhibitorji v napredovanju raka: možna uporaba v prognozi, preventivi in antimetastatski terapiji (Slovene) |
1/1/1997
-
12/31/1999 |
PhD Tamara Lah Turnšek
|
3,650 |
| 185. |
L3-8847 |
Pozitronska emisijska tomografija (Slovene) |
7/1/1997
-
6/30/1999 |
PhD Nataša Budihna
|
1,487 |
| 186. |
J3-8922 |
Metastaze pri hitro rastočih tumorjih (Slovene) |
1/1/1997
-
12/31/1998 |
|
25 |
| 187. |
L1-8877 |
Razvoj polvodniških detektorjev za rentgensko slikanje (Slovene) |
1/1/1997
-
12/31/1998 |
PhD Vladimir Cindro
|
1,839 |
| 188. |
L3-8755 |
Uvedba stereotaktične radiokirurgije z lin. pospeševalnikom v Sloveniji (Slovene) |
1/1/1997
-
12/31/1998 |
PhD Marjan Budihna
|
297 |
| 189. |
L3-8754 |
Dodatno sistemsko zdravljenje bolnic z rakom dojk stadijev I in II (Slovene) |
1/1/1997
-
10/31/1998 |
PhD Jurij Lindtner
|
1,578 |
| 190. |
L1-7379 |
Raziskave možnih implementacij dezmuramilnih analogov MDP in rekombinatnih analogov TNF-a v terapiji (Slovene) |
1/1/1996
-
6/30/1998 |
PhD Anton Štalc
|
6,013 |
